Pharmacielo (PHCEF) Stock Price, News & Analysis

Company Overview

Pharmacielo SA is a Brazil-based vertically integrated medical cannabis company focused on the development, cultivation and production of pharmaceutical-grade cannabinoid products. The company operates state-of-the-art cultivation sites in Minas Gerais and a Good Manufacturing Practice (GMP)–certified extraction and processing facility in Piracicaba. Pharmacielo’s product portfolio includes full-spectrum oils, capsules, topical formulations and customized cannabinoid blends, designed to address a variety of therapeutic applications such as pain management, neurological disorders and dermatological conditions.

Since its establishment, Pharmacielo has pursued research collaborations with academic institutions and biotechnology partners to advance clinical studies and improve extraction technologies. The company holds cultivation and processing licenses from Brazil’s National Health Surveillance Agency (ANVISA) and has implemented a quality management system aligned with international pharmaceutical standards. Pharmacielo’s supply chain extends throughout Brazil, with distribution agreements in several Latin American markets, and it is evaluating regulatory pathways to export finished products to Europe and other jurisdictions.

Founded in 2017, Pharmacielo underwent strategic growth in 2021 by completing a dual listing on the Canadian Securities Exchange (CSE) and initiating trading on the US OTC markets under the symbol PHCEF. This capital market milestone provided the company with enhanced access to North American investors and positioned it for further expansion of cultivation capacity, product offerings and R&D programs.

The company’s leadership team combines seasoned professionals from the pharmaceutical, agronomic and biotech sectors, with executive experience in regulatory affairs, quality control and international business development. Guided by this experienced management group, Pharmacielo continues to invest in technology-driven agriculture, product innovation and strategic partnerships to solidify its presence in the rapidly evolving medical cannabis industry.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.03 to $0.05
• 52-Week Range: $1.90 to $9.98
• Volume: 595 shs
• Average Volume: 64,155 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PHCEF Stock Analysis - Frequently Asked Questions

How have PHCEF shares performed this year?

Pharmacielo's stock was trading at $0.0576 at the beginning of 2025. Since then, PHCEF shares have decreased by 37.5% and is now trading at $0.0360.

How do I buy shares of Pharmacielo?

Shares of PHCEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PHCEF
• CIK: N/A
• Web: www.pharmacielo.com
• Phone: 647-560-4640
• Fax: N/A
• Employees: 49
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A